Literature DB >> 18343983

A comparison between polymeric microsphere and bacterial vectors for macrophage P388D1 gene delivery.

Saba Parsa1, Yong Wang, Jason Fuller, Robert Langer, Blaine A Pfeifer.   

Abstract

PURPOSE: The purpose of this study was to compare bacterial and polymeric gene delivery devices for the ability to deliver plasmid DNA to a murine macrophage P388D1 cell line.
METHODS: An 85:15 ratio of poly(lactic-co-glycolic acid) (PLGA) and poly(beta-amino ester) polymers were formulated into microspheres that physically entrapped plasmid DNA encoding for the firefly luciferase reporter gene; whereas, the same plasmid was biologically transformed into a strain of Escherichia coli engineered to produce recombinant listeriolysin O. The two delivery devices were then tested for gene delivery and dosage effects using a macrophage cell line with both assays taking advantage of a 96-well high throughput format to quantify and compare each vector type.
RESULTS: Gene delivery was comparable for both vectors at higher vector dosages while lower dosages showed an improved delivery for the microsphere vectors. Delivery efficiency (defined as luciferase measurement/mg cellular protein/ng DNA delivered) was 881 luminescence mg(-1) ng(-1) for polymeric microspheres compared to 171 luminescence mg(-1) ng(-1) for the bacterial vectors.
CONCLUSION: A first head-to-head comparison between polymeric and bacterial gene delivery vectors shows a delivery advantage for polymeric microspheres that must also be evaluated in light of vector production, storage, and future potential.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343983     DOI: 10.1007/s11095-008-9563-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 2.  Bacteria as gene delivery vectors for mammalian cells.

Authors:  C Grillot-Courvalin; S Goussard; P Courvalin
Journal:  Curr Opin Biotechnol       Date:  1999-10       Impact factor: 9.740

Review 3.  Dendritic cells in cancer immunotherapy.

Authors:  L Fong; E G Engleman
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 4.  Engineering bacterial vectors for delivery of genes and proteins to antigen-presenting cells.

Authors:  Saba Parsa; Blaine Pfeifer
Journal:  Mol Pharm       Date:  2007-01-19       Impact factor: 4.939

5.  Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells.

Authors:  M Svensson; B Stockinger; M J Wick
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

Review 6.  Listeriolysin O: a key protein of Listeria monocytogenes with multiple functions.

Authors:  Samer Kayal; Alain Charbit
Journal:  FEMS Microbiol Rev       Date:  2006-07       Impact factor: 16.408

7.  A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy.

Authors:  K J Radford; D E Higgins; S Pasquini; E J Cheadle; L Carta; A M Jackson; N R Lemoine; G Vassaux
Journal:  Gene Ther       Date:  2002-11       Impact factor: 5.250

8.  Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?

Authors:  L Thiele; B Rothen-Rutishauser; S Jilek; H Wunderli-Allenspach; H P Merkle; E Walter
Journal:  J Control Release       Date:  2001-09-11       Impact factor: 9.776

9.  An investigation into the pathogenic properties of Escherichia coli strains BLR, BL21, DH5alpha and EQ1.

Authors:  H Chart; H R Smith; R M La Ragione; M J Woodward
Journal:  J Appl Microbiol       Date:  2000-12       Impact factor: 3.772

10.  Phagocytosis of antigens by Langerhans cells in vitro.

Authors:  C Reis e Sousa; P D Stahl; J M Austyn
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.

Authors:  Andrew B Hill; Mingfu Chen; Chih-Kuang Chen; Blaine A Pfeifer; Charles H Jones
Journal:  Trends Biotechnol       Date:  2015-12-23       Impact factor: 19.536

2.  A Low Protein Binding Cationic Poly(2-oxazoline) as Non-Viral Vector.

Authors:  Zhijian He; Lei Miao; Rainer Jordan; Devika S-Manickam; Robert Luxenhofer; Alexander V Kabanov
Journal:  Macromol Biosci       Date:  2015-04-02       Impact factor: 4.979

3.  Hybrid biosynthetic gene therapy vector development and dual engineering capacity.

Authors:  Charles H Jones; Anitha Ravikrishnan; Mingfu Chen; Ryan Reddinger; Mahmoud Kamal Ahmadi; Snehal Rane; Anders P Hakansson; Blaine A Pfeifer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

4.  Influence of molecular weight upon mannosylated bio-synthetic hybrids for targeted antigen presenting cell gene delivery.

Authors:  Charles H Jones; Akhila Gollakota; Mingfu Chen; Tai-Chun Chung; Anitha Ravikrishnan; Guojian Zhang; Blaine A Pfeifer
Journal:  Biomaterials       Date:  2015-05-11       Impact factor: 12.479

5.  Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration.

Authors:  Ryan Gene Soderquist; Evan M Sloane; Lisa C Loram; Jacqueline A Harrison; Ellen C Dengler; Scott M Johnson; Luke D Amer; Courtney S Young; Makenzie T Lewis; Stephen Poole; Matthew G Frank; Linda R Watkins; Erin D Milligan; Melissa J Mahoney
Journal:  Pharm Res       Date:  2010-03-12       Impact factor: 4.200

6.  Overcoming nonviral gene delivery barriers: perspective and future.

Authors:  Charles H Jones; Chih-Kuang Chen; Anitha Ravikrishnan; Snehal Rane; Blaine A Pfeifer
Journal:  Mol Pharm       Date:  2013-10-16       Impact factor: 4.939

7.  Polymyxin B treatment improves bactofection efficacy and reduces cytotoxicity.

Authors:  Charles H Jones; Snehal Rane; Emily Patt; Anitha Ravikrishnan; Chih-Kuang Chen; Chong Cheng; Blaine A Pfeifer
Journal:  Mol Pharm       Date:  2013-10-18       Impact factor: 4.939

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.